Ratings by Benchmark (Bruce Jackson)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/12/2026 | MiniMed Group | MMED | Maintain | Buy (Buy) |
|
Details | ||
| 6/4/2026 | MiniMed Group | MMED | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2026 | VolitionRX | VNRX | Maintain | Hold (Hold) |
|
Details | ||
| 6/2/2026 | Unicycive Therapeutics | UNCY | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/27/2026 | Insulet Corporation | PODD | Maintain | Buy (Buy) |
|
Details | ||
| 5/19/2026 | Milestone Scientific | MLSS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/19/2026 | Biofrontera | BFRI | Downgrade | Speculative Buy (Buy) |
0.79 (0.99) |
25.32% | Details | |
| 5/15/2026 | CapsoVision Inc | CV | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/15/2026 | DexCom | DXCM | Maintain | Buy (Buy) |
|
Details | ||
| 5/11/2026 | Insulet Corporation | PODD | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | DexCom | DXCM | New Coverage | Buy (N/A) |
60.61 (72.47) |
19.57% | Details | |
| 5/11/2026 | MiniMed Group | MMED | New Coverage | Buy (N/A) |
11.57 (14.77) |
27.66% | Details | |
| 5/11/2026 | Tandem Diabetes Care | TNDM | New Coverage | Hold (N/A) |
15.48 (15.30) |
-1.16% | Details | |
| 4/29/2026 | Neogenomics | NEO | Upgrade | Buy (Hold) |
9.02 (11.13) |
23.39% | Details | |
| 4/6/2026 | Unicycive Therapeutics | UNCY | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/2/2026 | Milestone Scientific | MLSS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 4/2/2026 | VolitionRX | VNRX | Maintain | Hold (Hold) |
|
Details | ||
| 3/27/2026 | CapsoVision Inc | CV | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/16/2026 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/13/2026 | The Beauty Health Company | SKIN | Maintain | Hold (Hold) |
|
Details | ||
| 3/13/2026 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 2/18/2026 | Neogenomics | NEO | Maintain | Hold (Hold) |
|
Details | ||
| 12/31/2025 | CapsoVision Inc | CV | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 12/4/2025 | Clene, Inc. | CLNN | Maintain | Buy (Buy) |
|
Details | ||
| 11/24/2025 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
100.90 (104.91) |
3.97% | Details | |
| 11/20/2025 | Clene, Inc. | CLNN | Maintain | Buy (Buy) |
|
Details | ||
| 11/20/2025 | Milestone Scientific | MLSS | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/14/2025 | Biofrontera | BFRI | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2025 | CapsoVision Inc | CV | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 11/4/2025 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2025 | Biofrontera | BFRI | Maintain | Buy (Buy) |
|
Details | ||
| 9/30/2025 | Exact Sciences | EXAS | Maintain | Buy (Buy) |
|
Details | ||
| 9/26/2025 | Clene, Inc. | CLNN | Maintain | Buy (Buy) |
|
Details | ||
| 9/15/2025 | Milestone Scientific | MLSS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/15/2025 | VolitionRX | VNRX | Maintain | Hold (Hold) |
|
Details | ||
| 9/15/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/15/2025 | Unicycive Therapeutics | UNCY | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/10/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/10/2025 | Clene, Inc. | CLNN | Maintain | Buy (Buy) |
|
Details | ||
| 7/28/2025 | CapsoVision Inc | CV | New Coverage | Speculative Buy (N/A) |
4.00 (6.61) |
65.25% | Details | |
| 7/18/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/23/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/21/2025 | Unicycive Therapeutics | UNCY | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/21/2025 | Milestone Scientific | MLSS | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 5/19/2025 | VolitionRX | VNRX | Maintain | Hold (Hold) |
|
Details | ||
| 5/19/2025 | Biofrontera | BFRI | Maintain | Buy (Buy) |
|
Details | ||
| 5/13/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/8/2025 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | Milestone Scientific | MLSS | Maintain | Buy (Buy) |
|
Details | ||
| 4/14/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 4/9/2025 | Reviva Pharmaceuticals | RVPH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 4/8/2025 | VolitionRX | VNRX | Maintain | Hold (Hold) |
|
Details | ||
| 3/31/2025 | Neogenomics | NEO | Maintain | Hold (Hold) |
|
Details | ||
| 3/28/2025 | Exact Sciences | EXAS | Maintain | Buy (Buy) |
|
Details | ||
| 3/26/2025 | The Beauty Health Company | SKIN | Maintain | Hold (Hold) |
|
Details | ||
| 3/24/2025 | Biofrontera | BFRI | Maintain | Buy (Buy) |
|
Details | ||
| 3/24/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 3/24/2025 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 1/16/2025 | Neogenomics | NEO | Maintain | Hold (N/A) |
|
Details | ||
| 1/13/2025 | Neogenomics | NEO | Downgrade | Hold (Buy) |
14.77 (9.02) |
-38.93% | Details | |
| 11/22/2024 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2024 | Milestone Scientific | MLSS | Downgrade | Speculative Buy (Buy) |
0.62 (0.37) |
-40.32% | Details | |
| 11/6/2024 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2024 | Hoth Therapeutics | HOTH | Maintain | Speculative Buy (Speculative Buy) |
|
Details | ||
| 9/24/2024 | Neogenomics | NEO | Maintain | Buy (Buy) |
|
Details | ||
| 8/27/2024 | Modular Medical inc. | MODD | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/27/2024 | Modular Medical inc. | MODD | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/15/2024 | Move, Inc. | MOVE | Downgrade | Speculative Buy (Buy) |
0.35 (22.53) |
6337.14% | Details | |
| 8/9/2024 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/1/2024 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2024 | Move, Inc. | MOVE | New Coverage | Speculative Buy (N/A) |
0.38 (22.53) |
5828.95% | Details | |
| 6/6/2024 | Cardio Diagnostics Holdings, Inc. | CDIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/19/2024 | Cardio Diagnostics Holdings, Inc. | CDIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/15/2024 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/8/2024 | Know Labs | KNW | New Coverage | Speculative Buy (N/A) |
0.64 (2.14) |
234.38% | Details | |
| 3/13/2024 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 1/2/2024 | Exact Sciences | EXAS | Upgrade | Buy (Hold) |
73.98 (104.91) |
41.81% | Details | |
| 11/15/2023 | Tenon Medical Inc. | TNON | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/14/2023 | The Beauty Health Company | SKIN | Downgrade | Hold (Buy) |
3.90 (0.66) |
-83.08% | Details | |
| 9/21/2023 | Seelos Therapeutics | SEEL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 9/15/2023 | STAAR Surgical | STAA | Downgrade | Hold (Buy) |
42.87 (29.12) |
-32.07% | Details | |
| 8/24/2023 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/9/2023 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Exact Sciences | EXAS | Downgrade | Hold (Buy) |
96.44 (73.98) |
-23.29% | Details | |
| 7/26/2023 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 7/21/2023 | CytoMed Therapeutics | GDTC | New Coverage | Speculative Buy (N/A) |
3.85 (1.08) |
-71.95% | Details | |
| 6/30/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2023 | Reviva Pharmaceuticals | RVPH | New Coverage | Speculative Buy (N/A) |
7.16 (0.35) |
-95.11% | Details | |
| 5/10/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 4/10/2023 | Clene, Inc. | CLNN | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2023 | Seelos Therapeutics | SEEL | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/15/2023 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/10/2023 | Harvard Bioscience Inc. | HBIO | Upgrade | Buy (Speculative Buy) |
2.66 (5.87) |
120.68% | Details | |
| 2/24/2023 | Neogenomics | NEO | Upgrade | Buy (Hold) |
16.63 (11.13) |
-33.07% | Details | |
| 2/1/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2023 | VolitionRX | VNRX | Downgrade | Hold (Buy) |
2.47 (1.43) |
-42.11% | Details | |
| 1/10/2023 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/23/2022 | Orgenesis | ORGS | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2022 | Hoth Therapeutics | HOTH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/16/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/10/2022 | Harvard Bioscience Inc. | HBIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 11/3/2022 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2022 | Cardio Diagnostics Holdings, Inc. | CDIO | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 8/26/2022 | Neogenomics | NEO | Downgrade | Hold (Buy) |
11.70 (11.13) |
-4.87% | Details | |
| 8/11/2022 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Heart Test Laboratories Inc. | HSCS | New Coverage | Speculative Buy (N/A) |
2.12 (1.84) |
-13.21% | Details | |
| 8/3/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2022 | Invitae Corporation | NVTA | Downgrade | Hold (Buy) |
2.67 (0.02) |
-99.25% | Details | |
| 6/21/2022 | Tenon Medical Inc. | TNON | New Coverage | Speculative Buy (N/A) |
2.16 (0.35) |
-83.8% | Details | |
| 5/27/2022 | Hoth Therapeutics | HOTH | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 5/17/2022 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/28/2022 | STAAR Surgical | STAA | Upgrade | Buy (Neutral) |
72.95 (29.12) |
-60.08% | Details | |
| 3/22/2022 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2022 | Exact Sciences | EXAS | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2021 | Invitae Corporation | NVTA | Upgrade | Buy (Hold) |
28.50 (0.02) |
-99.93% | Details | |
| 7/20/2021 | Alpha Healthcare Acquisition Corp. | AHAC | New Coverage | Buy (N/A) |
9.97 (10.96) |
9.93% | Details | |
| 6/28/2021 | The Beauty Health Company | SKIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Vesper Healthcare | VSPR | New Coverage | Buy (N/A) |
11.22 (12.49) |
11.32% | Details | |
| 3/17/2021 | OncoCyte Corp | OCX | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 3/9/2021 | Seelos Therapeutics | SEEL | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2021 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2021 | STAAR Surgical | STAA | Downgrade | Hold (Buy) |
90.99 (29.12) |
-68% | Details | |
| 1/7/2021 | Harvard Bioscience Inc. | HBIO | Upgrade | Buy (Speculative Buy) |
4.27 (5.87) |
37.47% | Details | |
| 1/7/2021 | OncoCyte Corp | OCX | Upgrade | Buy (Speculative Buy) |
2.53 (3.20) |
26.48% | Details | |
| 7/1/2020 | Invitae Corporation | NVTA | Downgrade | Hold (Buy) |
30.29 (0.02) |
-99.93% | Details | |
| 6/17/2020 | Chembio Diagnostics | CEMI | Downgrade | Hold (Buy) |
9.93 (0.46) |
-95.37% | Details | |
| 4/2/2020 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2020 | LHC Group | LHCG | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | Chembio Diagnostics | CEMI | Maintain | Speculative Buy (N/A) |
|
Details | ||
| 2/28/2020 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 12/27/2019 | Flexion Therapeutics | FLXN | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2019 | Harvard Bioscience Inc. | HBIO | Downgrade | Speculative Sell (Buy) |
2.94 (5.87) |
99.66% | Details | |
| 11/20/2019 | Biofrontera AG | BFRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2019 | STAAR Surgical | STAA | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2019 | Hoth Therapeutics | HOTH | New Coverage | Speculative Buy (N/A) |
4.24 (1.36) |
-67.92% | Details | |
| 9/26/2019 | Orgenesis | ORGS | New Coverage | Speculative Sell (N/A) |
4.20 (2.11) |
-49.76% | Details | |
| 9/23/2019 | Exact Sciences | EXAS | Upgrade | Buy (Hold) |
103.97 (104.91) |
0.9% | Details | |
| 7/31/2019 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2019 | Flexion Therapeutics | FLXN | Upgrade | Buy (Hold) |
10.24 (25.11) |
145.21% | Details | |
| 1/4/2019 | Flexion Therapeutics | FLXN | Downgrade | Hold (Buy) |
12.46 (10.24) |
-17.82% | Details | |
| 11/1/2018 | Neogenomics | NEO | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | Exact Sciences | EXAS | New Coverage | Hold (N/A) |
77.60 (103.97) |
33.98% | Details |
